Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

medac uk - hydroxycarbamide - oral capsule - 500mg

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - hydroxycarbamide - oral capsule - 500mg

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - hydroxycarbamide (hydroxyurea), quantity: 500 mg - capsule, hard - excipient ingredients: indigo carmine; dibasic sodium phosphate heptahydrate; magnesium stearate; titanium dioxide; citric acid; lactose monohydrate; iron oxide yellow; gelatin; erythrosine; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; strong ammonia solution; ethanol absolute; iron oxide black; ethanol; shellac; sulfuric acid - significant tumour response to hydrea has been demonstrated in, chronic myelocytic leukaemia (pretreatment phase and palliative care) and recurrent, metastatic, or inoperable carcinoma of the ovary.

Armenia - engelsk - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

medac gmbh - hydroxycarbamide - capsules - 500mg

Belgia - nederlandsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cheplapharm arzneimittel gmbh - hydroxycarbamide 500 mg - capsule, hard - 500 mg - hydroxycarbamide 500 mg - hydroxycarbamide

Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cheplapharm arzneimittel gmbh - hydroxycarbamide 500 mg - gélule - 500 mg - hydroxycarbamide 500 mg - hydroxycarbamide

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

nordic pharma ltd - hydroxycarbamide - tablet - 1gram

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

nordic pharma ltd - hydroxycarbamide - tablet - 100mg

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - hydroxycarbamide (hydroxyurea), quantity: 500 mg - capsule, hard - excipient ingredients: erythrosine; magnesium stearate; titanium dioxide; gelatin; indigo carmine; lactose monohydrate; quinoline yellow; dibasic sodium phosphate; citric acid; sodium lauryl sulfate - significant tumour response to hydroxycarbamide (hydroxyurea) has been demonstrated in chronic myelocytic leukaemia (pretreatment phase and palliative care) and recurrent, metastatic, or inoperable carcinoma of the ovary.

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - hydroxycarbamide - oral solution - 100mg/1ml